Pharmaceutical

MeiraGTx seeks UK approval after gene therapy restores sight in children born blind

MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind.

Feb 25, 2025 - 06:00
MeiraGTx seeks UK approval after gene therapy restores sight in children born blind
MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind.
Read the original article

Tags:

Previous Article

Semaglutide shortage ends as FDA sets deadline for compounders

Next Article

Teva and Alvotech launch ustekinumab biosimilar injection in US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors

STAT+: Pharmalittle: Weight loss drugs are being paired...

Dec 19, 2023

STAT+: Sanders, other lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers

STAT+: Sanders, other lawmakers open probe into asthma ...

Jan 8, 2024

AstraZeneca’s sBLA for LS-SCLC treatment gains FDA priority review

AstraZeneca’s sBLA for LS-SCLC treatment gains FDA prio...

Aug 17, 2024